0001209191-18-053449.txt : 20181002 0001209191-18-053449.hdr.sgml : 20181002 20181002185008 ACCESSION NUMBER: 0001209191-18-053449 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180928 FILED AS OF DATE: 20181002 DATE AS OF CHANGE: 20181002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knickerbocker Aron Marc CENTRAL INDEX KEY: 0001578766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 181103111 MAIL ADDRESS: STREET 1: C/O FIVE PRIME THERAPEUTICS, INC. STREET 2: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-28 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001578766 Knickerbocker Aron Marc 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President & CEO Common Stock 2018-09-28 4 A 0 1775 0.00 A 197920 D Common Stock 2018-09-28 4 F 0 954 13.92 D 196966 D Common Stock 14238 I By the Aron M. Knickerbocker Revocable Trust Represents shares of common stock that were delivered to the reporting person on September 28, 2018 upon achievement of a performance-based condition applicable to a restricted stock award granted to the reporting person on February 7, 2017. /s/ Francis Sarena, Attorney-in-fact 2018-10-02